MRNA Vaccines, Once a Trump Boast, Now Face Attacks From Some in GOP
Republicans have proposed legislation in several states to ban the pioneering technology used in covid shots. Many doctors worry a huge medical advance could be rolled back.
FDA
81 - 100 of 476 Results
-
-
How the FDA Opens the Door to Risky Chemicals in America’s Food Supply
The FDA has relied on food companies for decades to determine whether their ingredients are safe. Some chemicals and additives are tied to health risks while others are absent from product labels.
-
Marty Makary, Often Wrong as Pandemic Critic, Is Poised To Lead the FDA He Railed Against
Should Marty Makary take the reins at the FDA, transitioning from gadfly to the head of an agency that regulates a fifth of the U.S. economy, he would have to engage in the thorny challenges of governing.
By Arthur Allen The State of Federal Health Agencies Is Uncertain
Episode 387The Supreme Court opined for the first time that Trump administration officials may be exceeding their authority to reshape the federal government by refusing to honor completed contracts, even as lower-court judges started blocking efforts to fire workers, freeze funding, and cancel ongoing contracts. Meanwhile, public health officials are alarmed at the Department of Health and Human Services鈥 public handling of Texas鈥 widening measles outbreak, particularly the secretary鈥檚 less-than-full endorsement of vaccines. Lauren Weber of The Washington Post, Joanne Kenen of the Johns Hopkins University School of Public Health and Politico Magazine, and Stephanie Armour of 吃瓜不打烊 join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more.
Medicaid in the Crosshairs, Maybe
Episode 385President Donald Trump has said he won鈥檛 support major cuts to the Medicaid health insurance program for people with low incomes, but he has endorsed a House budget plan that calls for major cuts, leaving the program鈥檚 future in doubt. Meanwhile, thousands of workers at the Department of Health and Human Services were fired over the holiday weekend, from the National Institutes of Health, the FDA, and the Centers for Disease Control and Prevention, with possibly more cuts to come.
Alice Miranda Ollstein of Politico, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, and Sarah Karlin-Smith of the Pink Sheet join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more.
RFK Jr. in the Hot Seat
Episode 382President Donald Trump鈥檚 choice to lead the vast Department of Health and Human Services, Robert F. Kennedy Jr., faced sharp questioning from senators this week, particularly over his history of vaccine denialism. Meanwhile, the Trump administration鈥檚 second week has been even more disruptive than its first, with an on-again, off-again funding freeze that left many around the country scrambling to understand what was going on. Sandhya Raman of CQ Roll Call and Sarah Karlin-Smith of the Pink Sheet join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Nicholas Bagley, a University of Michigan law professor, who explains how the federal regulatory system is supposed to operate to make health policy.
-
Led by RFK Jr., Conservatives Embrace Raw Milk. Regulators Say It鈥檚 Dangerous.
Controversy over raw milk reflects the push-pull the Trump administration faces in rolling back regulations and offering consumers more choices. For now, the CDC still recommends against consuming raw milk and the FDA bans its interstate sale.
-
What RFK Jr. Might Face in His Nomination Hearings This Week
Two Senate committees are expected to question Robert F. Kennedy Jr. on how his disproven views of science and medicine qualify him to run the $1.7 trillion, 80,000-employee federal health system.
By Arthur Allen Creating Chaos at HHS
Episode 381President Donald Trump was sworn in Monday and by Wednesday had virtually stopped scientific policymaking at the Department of Health and Human Services. While incoming administrations often pause public communications, the acting HHS head ordered an unprecedented shutdown of all outside meetings, travel, and publications. Meanwhile, Trump issued a broad array of mostly nonbinding executive orders, but notably none directly concerning abortion. Rachel Cohrs Zhang of Stat, Alice Miranda Ollstein of Politico, and Rachel Roubein of The Washington Post join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Rodney Whitlock, a former congressional staffer, who explains the convoluted 鈥渂udget reconciliation鈥 process Republicans hope to use to enact Trump鈥檚 agenda.
-
Junk Food Turns Public Villain as Power Shifts in Washington
Some Trump insiders are ready to take on the food industry. It remains to be seen whether their entr茅e will result in any meaningful change in government oversight of 鈥淏ig Food鈥 鈥 or in American health.
By Stephanie Armour and David Hilzenrath Hello, Trump. Bye-Bye, Biden.
Episode 380With just days to go before the official launch of a new administration, the GOP-led Congress is putting together plans on how to enact incoming President Donald Trump鈥檚 agenda, with a particular emphasis on cutting spending on the Medicaid program. Meanwhile, the Biden administration makes major moves in its last days, including banning a controversial food dye and ordering cigarette companies to minimize their nicotine content. Joanne Kenen of Johns Hopkins University and Politico Magazine, Anna Edney of Bloomberg News, and Sandhya Raman of CQ Roll Call join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Harris Meyer, who reported and wrote the latest 吃瓜不打烊 鈥淏ill of the Month鈥 feature, about a colonoscopy that came with a much larger price tag than estimated.
-
How America Lost Control of the Bird Flu, Setting the Stage for Another Pandemic
Exclusive reporting reveals how the United States lost track of a virus that could cause the next pandemic. Problems like the sluggish pace of federal action, deference to industry, and neglect for the safety of low-wage workers put the country at risk of another health emergency.
By Amy Maxmen -
Trump鈥檚 Picks for Top Health Jobs Not Just Team of Rivals but 鈥楾eam of Opponents鈥
The president-elect鈥檚 choices to lead the Department of Health and Human Services, as well as agencies such as the National Institutes of Health, FDA, and CDC, hold positions on issues including abortion and vaccination that are often at odds.
By Stephanie Armour and Julie Rovner A Colorful Cast Could Lead Key Health Agencies
Episode 375President-elect Donald Trump has made his choices to fill some top jobs at the Department of Health and Human Services. They include controversial figures who were vocal critics of the Biden administration鈥檚 handling of the covid pandemic and have proposed sweeping changes to the agencies they would lead. Meanwhile, the Supreme Court heard its first two health-related cases of the term, challenging a Tennessee law barring transgender medical care for minors and, separately, challenging the FDA鈥檚 handling of e-cigarettes. Joanne Kenen of the Johns Hopkins University and Politico, Shefali Luthra of The 19th, and Sarah Karlin-Smith of the Pink Sheet join 吃瓜不打烊鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews 吃瓜不打烊鈥 Bram Sable-Smith, who reported and wrote the latest 吃瓜不打烊-Washington Post Well+Being 鈥淏ill of the Month鈥 feature, about an emergency room bill for a visit that didn鈥檛 get past the waiting room.
-
Make America Healthy Again: An Unconventional Movement That May Have Found Its Moment
Nonmainstream doctors and leaders in health business are wielding serious muscle in shaping the incoming Trump administration鈥檚 health policies and challenging prevailing thinking on public health, disease prevention, and chronic illness.
-
Florida Gov. DeSantis鈥 Canadian Drug Import Plan Goes Nowhere After FDA Approval
Florida sued the FDA over what it said was a 鈥渞eckless delay鈥 in approving its drug importation plan. Now, nearly a year after the FDA gave the state the green light, the program has yet to begin.
-
-
Scientists Fear What鈥檚 Next for Public Health if RFK Jr. Is Allowed To 鈥楪o Wild鈥
As federal health scientists await a potential takeover by RFK Jr. and other medical skeptics in the second Trump administration, some are preparing r茅sum茅s or retirement papers.
By Arthur Allen -
No Evidence Trump鈥檚 Drug Program for Terminal Patients Saved 鈥楾housands鈥 of Lives
Though the former president has repeatedly hyped the impact of his experimental drug program, there鈥檚 no basis for his claims in government data, and medical experts say he鈥檚 exaggerating.
-
What鈥檚 at Stake: A Pivotal Election for Six Big Health Issues
Health care has ebbed and surged as an election issue throughout the presidential campaign. Here are the ways some of the most consequential changes in health policies could hinge on whether Vice President Kamala Harris or former President Donald Trump wins.